会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Ovary-specific genes and proteins
    • 子宫特异性基因和蛋白质
    • US20060069243A1
    • 2006-03-30
    • US11270717
    • 2005-11-09
    • Martin MatzukPei Wang
    • Martin MatzukPei Wang
    • C07K14/72C07K14/575C07H21/04C12N1/21C12N15/74
    • C07K14/47
    • Ovary specific proteins O1 180, O1 184 and O1 236, polynucleotides encoding them, antibodies which are immunoreactive with them and vectors and host cells containing O1 180, O1 184 or O1 236 are provided. Also provided are methods for detecting cell proliferative or degenerative disorders of ovarian origin and which are associated with O1 180, O1 184 or O1 236. Further provided are methods for the evaluation of potential contraceptives using the proteins of the invention, as well as methods for the screening for genetic mutations in signaling pathways that are associated with some forms of human infertility or gynecological cancers, also using the proteins/mRNAs/genes of the invention. The proteins/mRNAs/genes of the invention may also be used as markers for identifying primary and metastatic neoplasms of ovarian origin and as indicators of developmental anomalies in prenatal screening procedures. Furthermore, assays of the proteins/mRNAs/genes of the invention can be used in diagnostic assays for detecting forms of infertility and other diseases, including germ cell tumors and polycystic ovary syndrome. The proteins of the invention may be useful targets for in vitro fertilization procedures or in enhancing the number of eggs that can be retrieved from the human donor, e.g., in enhancing the success rate.
    • 卵巢特异性蛋白O1 180,O184和O1 236,编码它们的多核苷酸,与它们免疫反应的抗体和载体以及含有O1 180,O184或O1 236的宿主细胞。 还提供了用于检测卵巢起源的细胞增殖性或退行性病症的方法,其与O1 180,O1 184或O1 236相关。还提供了使用本发明的蛋白质评估潜在避孕药物的方法,以及用于 筛选与某些形式的人类不育症或妇科癌症相关的信号通路中的基因突变,也使用本发明的蛋白质/ mRNAs /基因。 本发明的蛋白质/ mRNAs /基因也可用作识别卵巢原发性和转移性肿瘤的标志物,以及作为产前筛查程序发育异常的指标。 此外,本发明的蛋白质/ mRNA /基因的测定可用于检测不育症和其他疾病形式的诊断测定,包括生殖细胞肿瘤和多囊卵巢综合征。 本发明的蛋白质可以是体外受精程序的有用靶标,或增强可从人类供体获取的卵数,例如提高成功率。
    • 6. 发明授权
    • Ovary-specific genes and proteins
    • 子宫特异性基因和蛋白质
    • US06995251B1
    • 2006-02-07
    • US09830810
    • 1999-10-28
    • Martin M. MatzukPei Wang
    • Martin M. MatzukPei Wang
    • C07H21/00
    • Ovary-specific proteins O1-180, O1-184 and O1-236, polynucleotides encoding them, antibodies which are immunoreactive with them and vectors and host cells containing O1-180, O1-184 or O1-236 are provided. Also provided are methods for detecting cell proliferative or degenerative disorders of ovarian origin and which are associated with O1-180, O1-184 or O1-236. Further provided are methods for the evaluation of potential contraceptives using the proteins of the invention, as well as methods for the screening for genetic mutations in signaling pathways that are associated with some forms of human infertility or gynecological cancers, also using the proteins/mRNAs/genes of the invention. The proteins/mRNAs/genes of the invention may also be used as markers for identifying primary and metastatic neoplasms of ovarian origin and as indicators of developmental anomalies in prenatal screening procedures. Furthermore, assays of the proteins/mRNAs/genes of the invention can be used in diagnostic assays for detecting forms of infertility and other diseases, including germ cell tumors and polycystic ovary syndrome. The proteins of the invention may be useful targets for in vitro fertilization procedures or in enhancing the number of eggs that can be retrieved from the human donor, e.g., in enhancing the success rate.
    • 提供卵巢特异性蛋白质O1-180,O1-184和O1-236,编码它们的多核苷酸,与它们免疫反应的抗体和载体以及含有O1-180,O1-184或O1-236的宿主细胞。 还提供了用于检测卵巢起源的细胞增殖或退行性疾病的方法,其与O1-180,O1-184或O1-236相关。 还提供了使用本发明的蛋白质评价潜在的避孕药物的方法,以及用于筛选与某些形式的人类不育症或妇科癌症相关的信号通路中的遗传突变的方法,也使用蛋白质/ mRNAs / 本发明的基因。 本发明的蛋白质/ mRNAs /基因也可用作识别卵巢原发性和转移性肿瘤的标志物,以及作为产前筛查程序发育异常的指标。 此外,本发明的蛋白质/ mRNA /基因的测定可用于检测不育症和其他疾病形式的诊断测定,包括生殖细胞肿瘤和多囊卵巢综合征。 本发明的蛋白质可以是体外受精程序的有用靶标,或增强可从人类供体获取的卵数,例如提高成功率。
    • 9. 发明授权
    • Assay for growth differentiation factor 9
    • 生长分化因子9的测定
    • US06680174B1
    • 2004-01-20
    • US09283909
    • 1999-04-01
    • Martin M. MatzukJulia A. ElvinPei Wang
    • Martin M. MatzukJulia A. ElvinPei Wang
    • G01N33567
    • G01N33/74G01N33/689G01N2333/475
    • The present invention relates to a method of identifying an agent which alters (inhibits, enhances) activity of GDF-9. The method involves combining cells having a receptor for GDF-9 and a gene, wherein expression of the gene is regulated by binding of GDF-9 to the receptor; GDF-9; and an agent to be assessed. The combination produced is maintained under conditions appropriate for binding of GDF-9 to the receptors on the cells. The extent to which binding of GDF-9 to the receptors on the cells occurs is then determined, wherein binding of GDF-9 to the receptor to a lesser or greater extent in the presence of the agent to be assessed than in its absence, is indicative of an agent which alters GDF-9 activity.
    • 本发明涉及鉴定改变(抑制,增强)GDF-9活性的试剂的方法。 该方法包括组合具有GDF-9受体的细胞和基因,其中基因的表达通过GDF-9与受体的结合来调节; GDF-9; 和待评估的代理人。 产生的组合保持在适合于将GDF-9与细胞上的受体结合的条件下。 然后确定GDF-9与细胞上的受体结合发生的程度,其中在待评估的试剂存在下,GDF-9与受体的结合程度要比在不存在的情况下更小或更大程度地结合, 表明改变GDF-9活动的药剂。